Dorthe Odyl Klein

Dr. Dorthe Odyl Klein

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2020 in Journal of Patient Safety
Verified
Journal Article
Open access
DKDorthe Odyl Klein
Dorthe Odyl Klein
RRRoger J.M.W. Rennenberg
Roger J.M.W. Rennenberg
RKRichard P. Koopmans
Richard P. Koopmans
MPMartin H. Prins
Martin H. Prins
Objective: In this systematic review, we evaluate 2 of the most used trigger tools according to the criteria of the World Health Organization for evaluating methods. Methods: We searched Embase, PubMed, and Cochrane databases for studies (2000–2017). Studies were included if medical record review (MRR) was performed with either the Global Trigger Tool or the Harvard Medical Practice Study in a hospital population. Quality assessment was performed in duplicate. Fifty studies were included, and results were reported for every criterion separately. Results: Medical record review reveals more adverse events (AEs) than any other method. However, at the same time, it detects different AEs. The costs of an AE were on average €4296. Considerable efforts have been made worldwide in health care to improve safety and to reduce errors. These have resulted in some positive effects. The literature showed that MRR is focused on several domains of quality of care and seems suitable for both small and large cohorts. Furthermore, we found a moderate to substantial agreement for the presence of a trigger and a moderate to good agreement for the presence of an AE. Conclusions: Medical record review with a trigger tool is a reasonably well-researched method for the evaluation of the medical records for AEs. However, looking at the World Health Organization criteria, much research is still lacking or of moderate quality. Especially for the cost of detecting AEs, valuable information is missing. Moreover, knowledge of how MRR changes quality and safety of care should be evaluated.

29 November 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DKDorthe Odyl Klein
Dorthe Odyl Klein
RRRoger J M W Rennenberg
Roger J M W Rennenberg
RKRichard P Koopmans
Richard P Koopmans
MPMartin H Prins
Martin H Prins
To assess the reproducibility of adverse event evaluation by a medical record review committee. Cross-sectional reanalysis of medical records. Reviewers re-examined fifty medical records of deceased patients regarding the presence of adverse events, their potential preventability and their possible contribution to death. Also we investigated the root causes of the preventable AEs. Differences between the first and second assessment were calculated. The Kappa on the presence of an adverse event was 0.64 and 0.32 for the potential preventability. The intrarater agreement showed a Kappa of 0.61 on the adverse event presence and 0.64 for the potential preventability. Interrater agreement showed a Kappa of 0.66 for the adverse event presence and 0.03 for the potential preventability. We found a fair reproducibility for the detection of adverse events, but a poor reproducibility for the potential preventability. Possibly this was caused by lack of a definition for the preventability of adverse events. We think giving feedback to professionals using the results of medical record review remains valuable, but an improvement of its reproducibility is essential. To our opinion an international consensus on what exactly constitutes preventability of adverse events and agreement on a definition is necessary. This would result in more comparable studies in this field and could then be more informative on the ideal procedure to avoid certain potentially preventable adverse events in the future.

2 June 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
DKDésirée Klemann
Désirée Klemann
MRMaud Rijkx
Maud Rijkx
HMHelen Mertens
Helen Mertens
FMFrits van Merode
Frits van Merode
DKDorthe Odyl Klein
Dorthe Odyl Klein
Background: Quality strategies, interventions, and frameworks have been developed to facilitate a better understanding of healthcare systems. Reporting adverse events is one of these strategies. Gynaecology and obstetrics are one of the specialties with many adverse events. To understand the main causes of medical errors in gynaecology and obstetrics and how they could be prevented, we conducted this systematic review. Methods: This systematic review was performed in compliance with the Prisma 2020 guidelines. We searched several databases for relevant studies (Jan 2010–May 2023). Studies were included if they indicated the presence of any potential risk factor at the hospital level for medical errors or adverse events in gynaecology or obstetrics. Results: We included 26 articles in the quantitative analysis of this review. Most of these (n = 12) are cross-sectional studies; eight are case–control studies, and six are cohort studies. One of the most frequently reported contributing factors is delay in healthcare. In addition, the availability of products and trained staff, team training, and communication are often reported to contribute to near-misses/maternal deaths. Conclusions: All risk factors that were found in our review imply several categories of contributing factors regarding: (1) delay of care, (2) coordination and management of care, and (3) scarcity of supply, personnel, and knowledge.

29 November 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
CGChahinda Ghossein-Doha
Chahinda Ghossein-Doha
MWMarieke S J N Wintjens
Marieke S J N Wintjens
EJEmma B N J Janssen
Emma B N J Janssen
DKDorthe Odyl Klein
Dorthe Odyl Klein
SHStella C M Heemskerk
Stella C M Heemskerk
SKSander M J van Kuijk
Sander M J van Kuijk
Introduction The variety, time patterns and long-term prognosis of persistent COVID-19 symptoms (long COVID-19) in patients who suffered from mild to severe acute COVID-19 are incompletely understood. Cohort studies will be combined to describe the prevalence of long COVID-19 symptoms, and to explore the pathophysiological mechanisms and impact on health-related quality of life. A prediction model for long COVID-19 will be developed and internally validated to guide care in future patients. Methods and analysis Data from seven COVID-19 cohorts will be aggregated in the longitudinal multiple cohort CORona Follow Up (CORFU) study. CORFU includes Dutch patients who suffered from COVID-19 at home, were hospitalised without or with intensive care unit treatment, needed inpatient or outpatient rehabilitation and controls who did not suffer from COVID-19. Individual cohort study designs were aligned and follow-up has been synchronised. Cohort participants will be followed up for a maximum of 24 months after acute infection. Next to the clinical characteristics measured in individual cohorts, the CORFU questionnaire on long COVID-19 outcomes and determinants will be administered digitally at 3, 6, 12, 18 and 24 months after the infection. The primary outcome is the prevalence of long COVID-19 symptoms up to 2 years after acute infection. Secondary outcomes are health-related quality of life (eg, EQ-5D), physical functioning, and the prevalence of thromboembolic complications, respiratory complications, cardiovascular diseases and endothelial dysfunction. A prediction model and a patient platform prototype will be developed. Ethics and dissemination Approval was obtained from the medical research ethics committee of Maastricht University Medical Center+ and Maastricht University (METC 2021-2990) and local committees of the participating cohorts. The project is supported by ZonMW and EuroQol Research Foundation. Results will be published in open access peer-reviewed scientific journals and presented at (inter)national conferences. Trial registration number NCT05240742.

3 November 2017 in Preventive Medicine Reports
Verified
Journal Article
Open access
PDF file
DKDorthe Odyl Klein
Dorthe Odyl Klein
RRRoger J.M.W. Rennenberg
Roger J.M.W. Rennenberg
RKRichard P. Koopmans
Richard P. Koopmans
MPMartin H. Prins
Martin H. Prins
Several trigger systems have been developed to screen medical records of hospitalized patients for adverse events (AEs). Because it's too labor-intensive to screen the records of all patients, usually a sample is screened. Our sample consists of patients who died during their stay because chances of finding preventable AEs in this subset are highest.

21 March 2024 in Journal of Patient Safety
Verified
Journal Article
Open access
JHJos Hj. Bsc Hoofs
Jos Hj. Bsc Hoofs
DKDorthe Odyl Klein
Dorthe Odyl Klein
ABAlan Bleakley
Alan Bleakley
RRRoger Jmw Rennenberg
Roger Jmw Rennenberg